Tatjana Vlajnic

University of Basel, University Hospital of Basel

Papers

2

Total Citations

22

H-Index

2

About

Dr. Tatjana Vlajnic is a leading pathologist whose work is transforming the precision of prostate cancer diagnosis and surgery. Her research centers on improving the detection and treatment of clinically significant prostate cancer by addressing the critical challenge of intralesional tumor heterogeneity. In her highly cited 2021 study (17 citations), Dr. Vlajnic demonstrated the diagnostic power of robotic-assisted MRI-US fusion targeted saturation biopsy, while crucially highlighting that standard sampling methods often miss aggressive cancer cells due to the tumor’s heterogeneous nature. This finding has direct implications for treatment planning. More recently, she has pioneered the use of personalized 3D-printed prostate models to guide secondary resection during robot-assisted radical prostatectomy, aiming to precisely remove positive surgical margins identified by frozen section analysis. This innovative approach, detailed in her 2024 work (5 citations), promises to preserve nerve-sparing outcomes while ensuring complete cancer removal. Dr. Vlajnic’s contributions are bridging the gap between advanced imaging, 3D technology, and surgical pathology, setting a new standard for personalized, precision-driven prostate cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
22
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Diagnostic accuracy and clinical implications of robotic assisted MRI-US fusion guided target saturation biopsy of the prostate
17 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: University of Basel, University Hospital of Basel

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago